InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes
The company’s new facilities add a large footprint of state-of-the-art laboratories and office space for scaling up InterVenn’s software development, technical support, clinical research and business development.